TYPE 1 DIABETES DILEMMA IN SUB-SAHARAN AFRICA
Abstract
Type 1 diabetes is a rigorously studied metabolic and human disease that mostly affects young people, and it is dependent upon human insulin and insulin analogs for its control. The Type 1 diabetes has low-frequency incidence in sub-Saharan Africa than I n more advanced societies, ostensibly due to delayed onset in Africa. However, it is projected that in the foreseeable future that the trend may metamorphose into an increase in the frequency rate in subSaharan Africa due to cross-cultural and other influences. Due to pecuniary difficulties, socioeconomic status and awareness, inadequate healthcare and clinical settings, the increase in morbidity and mortality associated with Type-1 diabetes may increase at a frightening rate in Sub-Saharan Africa.
Downloads
References
Makame, M, H. Childhood diabetes, insulin, and Africa. DERI (Diabetes Epidemiology Research International) Study Group. Diabet Med. 1992, 9(6):571-3.
Chukwuma Sr, C. Type 1 diabetic nephropathy: clinical characteristics and economic impact. J Diabetes Complications 1993, 7(1): 15-27.
Chukwuma Sr, C. Is diabetes a model for gene-environment interaction in premature senescence/ Journal of Biology, Agriculture and Healthcare Vol 4 No 5, 2014 https://www.iiste.org/Journals/index.php/JBAH/articleviewFile/17380/17802 .
Chukwuma Sr, C; Tuomilehto, J. The “thrifty” hypotheses: clinical and epidemiological significance for noninsulin-dependent diabetes mellitus and ardiovascular disease risk factors. J Cardiovasc Risk 1998, 5: 11-23.
Chukwuma Sr, C. Clinical, economic and health care constraints and challenges using insulin analogs in the treatment and control of diabetes in vulnerable populations. Acta Medica Science, AMS [Internet] 10 May 2017, 3(5): 12-5 http://asdpub.com/index.php/ams/article/view/355.
Beran, D; Yudkin, J, S; de Courten, M. Access to care for patients with insulinrequiring diabetes in developing countries: case studies of Mozambique and Zambia. Diabetes Care 2005, 28(9): 2136-4.
Otieno, C, F; Kayima, J, K; Omonge, E, O; Oyoo, G, O. Diabetic ketoacidosis: risk factors, mechanisms, and management strategies in sub-Saharan Africa: a review. East Afr Med J. 2005, 82(12 Suppl): S197-203.
Cadman B. What is refeeding? 2018. https://www.medicalnewstoday.com/arti cles/322120.php.
Ngai CN, Sobngwi E, Lontchi-Yimagou E, Mbanya A, Dehayem M, Etoga ME, Mbanya A, Dehayem M, Etoga ME, Mbanya J-C. Use of capillary ketones monitoring in the treatment of mild ketonic crisis in adults with ketosisprone atypical diabetes. PAMJ Conference Proceedings 2017; 2(2): 17.
Gill GV, Huddle KH, Monkoe G. Longterm (20 years) outcome and mortality of Type 1 diabetic patients in Soweto, South Africa. Diabet Med. 2005; 22(12): 1642-6.
Piloya-Were T, Sunn M, Ogle GD, Moran A. Childhood diabetes in Africa. Curr Opin Endocrinol Diabetes Obes 2016; 23(4): 306-11.
Majaliwa ES, Elusiyan BE, Adesiyun OO, Laigong P, Adeniran AK, Kandi CM, Yarhere I, Limbe SM, Iughetti L. Type `1 diabetes mellitus in the African population: epidemiology and management challenges. Acta Biomed, 2008; 79(3): 255-9.
Motala AA, Omar MA, Pirie FJ. Diabetes in Africa. Epidemiology of type 1 and type 2 diabetes in Africa. J Cardiovasc Risk 2003; (10(2): 77-83.
Park PH, Pastaki SD. Access to haemoglobin A1c in rural Africa: A difficult reality with severe consequences. J Diabetes Res 2018; doi:10.1155/2018/6093595.
Sehloho TSA, Van Zy DG. Effects of exogenous human insulin dose adjustment on body mass index in adult patients with type 1 diabetes mellitus at Kalafong Hospital, Pretoria, South Africa, 2009-2014. S Afr Med J 2017; 107(6): 528-534.
Matejko BH, kukulka A, Kiec-Wilk B, Stapor A, Klupa T, Malecki MT. Basal insulin dose in adults with type 1 diabetes mellitus on insulin pumps in real-life clinical practices: A single center experience. Advances in Medicine Volume 2018 Article ID 1473160, 5 pages.
Barnett AH. The role of GLP-mimetics and basal insulin analogs in type 2 diabetes mellitus: Guidance from studies of liraglutide. Diabetes Obesity and Metabolism, 2011; 14(4): 304-14.
(Fullerton B, Siebenhofer A, Jeitter K, Horvath K, Semlitsch T, Berghold A, Plank J, Pieber TR, Gerlach FM. Shortacting insulin analogs versus regular human insulin for adults with type 1 diabetes mellitus. Cochrane Database Syst Rev 2016; 30(6): CD012161.
Noorani M, Ramaiya K, Manji K. Glycaemic control in type 1 diabetes mellitus among children and adolescents in a resource-limited setting in Dar es Salaam – Tanzania. BMC Endocrine Disord 2016; 16(1): 29.
Bahendeka SK. Diabetes in sub-Saharan Africa: let us not forget type 1. The Lancet. Diabetes & Endocrinology 2017; 5(8): 595-77.
Chukwuma Sr C. Convergence on the constraints and challenges in the awareness, prevention, treatment, and control of type 2 diabetes and diabetesrelated conditions. Global Journal of Medical Research [S.I.] Jan 2018 https://medicalresearchjournal.org/index.php/GJMR/article/view/1415.
Steyn NP, Mchiza ZJ, Kengne AP. Future challenges for pediatric diabetes management in developing countries: lessons from Africa. Expert Rev Endocrinol Metab, 2015; 10(1): 75-86.
